Using beetroot juice to improve walking ability in patients with peripheral artery disease.
BEET root juice to reverse functional impairment in PAD: The BEET PAD Trial
This study is looking at whether drinking beetroot juice can help people with peripheral artery disease (PAD) walk better and feel stronger by improving blood flow to their legs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10924041 on NIH RePORTER |
What this research studies
This research investigates the effects of beetroot juice on patients with peripheral artery disease (PAD), a condition that causes reduced blood flow to the legs and leads to functional impairment. The study will involve a double-blind, randomized trial where participants will receive either beetroot juice or a placebo. Researchers aim to determine if beetroot juice can enhance blood flow, improve muscle function, and ultimately increase walking performance in individuals with PAD. The trial will include 210 participants and will measure improvements in walking ability over a four-month period.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with peripheral artery disease who experience difficulty walking.
Not a fit: Patients who do not have peripheral artery disease or those with severe comorbidities that limit mobility may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the walking ability and quality of life for patients suffering from peripheral artery disease.
How similar studies have performed: Previous pilot studies have shown promising results with beetroot juice improving walking ability in patients with PAD, indicating potential for success in this larger trial.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mcdermott, Mary Mcgrae — Northwestern University at Chicago
- Study coordinator: Mcdermott, Mary Mcgrae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.